Literature DB >> 16887500

Anaerobic infections in humans: an overview.

S M Finegold1.   

Abstract

Entities:  

Year:  1995        PMID: 16887500     DOI: 10.1016/s1075-9964(95)80340-8

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


× No keyword cloud information.
  20 in total

Review 1.  A primer on anaerobic bacteria and anaerobic infections for the uninitiated.

Authors:  I Olsen; C O Solberg; S M Finegold
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

2.  Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stability.

Authors:  H Oh; M Hedberg; D Wade; C Edlund
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

3.  16S ribosomal DNA sequence-based analysis of clinically significant gram-positive anaerobic cocci.

Authors:  Yuli Song; Chengxu Liu; Maureen McTeague; Sydney M Finegold
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Evaluation of 16S rRNA sequencing and reevaluation of a short biochemical scheme for identification of clinically significant Bacteroides species.

Authors:  Yuli Song; Chengxu Liu; Mauricio Bolanos; Julia Lee; Maureen McTeague; Sydney M Finegold
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  The role of anaerobic bacteria in upper respiratory tract and other head and neck infections.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

6.  Antibody response to Prevotella spp. in patients with ventilator-associated pneumonia.

Authors:  G Grollier; P Doré; R Robert; P Ingrand; C Gréjon; J L Fauchere
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

7.  Isolation, Identification and Antimicrobial Susceptibility of Anaerobic Bacteria: A Study Re-emphasizing Its Role.

Authors:  Ritu Garg; Neelam Kaistha; Varsha Gupta; Jagdish Chander
Journal:  J Clin Diagn Res       Date:  2014-11-20

8.  In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone.

Authors:  Kaori Tanaka; Hiroshige Mikamo; Ken'ichi Nakao; Kunitomo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

9.  gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.

Authors:  H Oh; N El Amin; T Davies; P C Appelbaum; C Edlund
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

10.  Current management of upper respiratory tract and head and neck infections.

Authors:  Itzhak Brook
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.